Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

LifeStance Health (LFST) Non-Current Debt (2021 - 2025)

LifeStance Health (LFST) has disclosed Non-Current Debt for 5 consecutive years, with $265.9 million as the latest value for Q4 2025.

  • On a quarterly basis, Non-Current Debt fell 4.95% to $265.9 million in Q4 2025 year-over-year; TTM through Dec 2025 was $265.9 million, a 4.95% decrease, with the full-year FY2025 number at $265.9 million, down 4.95% from a year prior.
  • Non-Current Debt was $265.9 million for Q4 2025 at LifeStance Health, down from $269.4 million in the prior quarter.
  • In the past five years, Non-Current Debt ranged from a high of $280.3 million in Q4 2023 to a low of $157.1 million in Q2 2021.
  • A 5-year average of $236.6 million and a median of $248.7 million in 2023 define the central range for Non-Current Debt.
  • Peak YoY movement for Non-Current Debt: skyrocketed 42.98% in 2022, then decreased 4.95% in 2025.
  • LifeStance Health's Non-Current Debt stood at $157.4 million in 2021, then soared by 42.98% to $225.1 million in 2022, then grew by 24.53% to $280.3 million in 2023, then fell by 0.18% to $279.8 million in 2024, then decreased by 4.95% to $265.9 million in 2025.
  • Per Business Quant, the three most recent readings for LFST's Non-Current Debt are $265.9 million (Q4 2025), $269.4 million (Q3 2025), and $272.9 million (Q2 2025).